ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experience.

Giulia Amadio Claudia Marchetti Emanuele Rocco Villani Domenico Fusco Francesca Stollagli Carolina Bottoni Mariagrazia Distefano Giuseppe Antonio Colloca Giovanni Scambia Anna Fagotti

Published in: Journal of gynecologic oncology (2019)

Elderly patients with EOC can safely be treated with bevacizumab; factors other than age, as higher creatinine serum levels, eGFR and number of comorbidities should be considered to better estimate bevacizumab-related toxicity risk.

Keyphrases

end stage renal disease
metastatic colorectal cancer
newly diagnosed
small cell lung cancer
ejection fraction
middle aged
chronic kidney disease
prognostic factors
peritoneal dialysis
community dwelling
epidermal growth factor receptor
oxidative stress
tyrosine kinase
uric acid
study protocol
drug induced